中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
11期
51-52
,共2页
邱军明%丘雪峰%杨燕娟%冯锦财
邱軍明%丘雪峰%楊燕娟%馮錦財
구군명%구설봉%양연연%풍금재
新生儿高胆红素血症%凝血功能
新生兒高膽紅素血癥%凝血功能
신생인고담홍소혈증%응혈공능
Neonatal hyperbilirubinemia%Coagulation
目的:探讨新生儿高胆红素血症对凝血功能的影响及其临床意义。方法:选取2013年1-6月于笔者所在医院出生的168例新生儿的凝血结果进行回顾性分析。将临床上诊断为新生儿高胆红素血症的108例新生儿设为研究组,包括新生儿病理性高胆红素血症组18例和生理性高胆红素血症组90例,将同期出生的60例正常足月儿设为对照组。对三组患儿的凝血结果进行统计分析。结果:病理性高胆红素血症组PT、APTT明显高于生理性高胆红素血症组,且两组明显高于对照组,差异有统计学意义(P<0.05)。结论:新生儿高胆红素血症可影响新生儿的凝血功能,临床上诊断及治疗新生儿出血性疾病的疗效时应排除高胆红素血症的影响。
目的:探討新生兒高膽紅素血癥對凝血功能的影響及其臨床意義。方法:選取2013年1-6月于筆者所在醫院齣生的168例新生兒的凝血結果進行迴顧性分析。將臨床上診斷為新生兒高膽紅素血癥的108例新生兒設為研究組,包括新生兒病理性高膽紅素血癥組18例和生理性高膽紅素血癥組90例,將同期齣生的60例正常足月兒設為對照組。對三組患兒的凝血結果進行統計分析。結果:病理性高膽紅素血癥組PT、APTT明顯高于生理性高膽紅素血癥組,且兩組明顯高于對照組,差異有統計學意義(P<0.05)。結論:新生兒高膽紅素血癥可影響新生兒的凝血功能,臨床上診斷及治療新生兒齣血性疾病的療效時應排除高膽紅素血癥的影響。
목적:탐토신생인고담홍소혈증대응혈공능적영향급기림상의의。방법:선취2013년1-6월우필자소재의원출생적168례신생인적응혈결과진행회고성분석。장림상상진단위신생인고담홍소혈증적108례신생인설위연구조,포괄신생인병이성고담홍소혈증조18례화생이성고담홍소혈증조90례,장동기출생적60례정상족월인설위대조조。대삼조환인적응혈결과진행통계분석。결과:병이성고담홍소혈증조PT、APTT명현고우생이성고담홍소혈증조,차량조명현고우대조조,차이유통계학의의(P<0.05)。결론:신생인고담홍소혈증가영향신생인적응혈공능,림상상진단급치료신생인출혈성질병적료효시응배제고담홍소혈증적영향。
Objective:To investigate neonatal hyperbilirubinemia on coagulation function and clinical significance.Method:Selection in the author's hospital between January and June 2013 was born in 168 cases of neonatal blood coagulation results were retrospectively analyzed. Will be clinically diagnosed as high neonatal bilirubin of 108 newborns is set to the team,including a newborn pathological high bilirubin blood disease group 18 cases and physiologic high bilirubin group 90 examples,will be born in the same period of 60 cases of normal full term set as control group. The coagulation results of three groups of children were analyzed.Result:The results of pathologic hyperbilirubinemia group PT,APTT was significantly higher than physiological hyperbilirubinemia group,and significantly higher in both groups,the difference was statistically significant (P<0.05). Conclusion:Neonatal hyperbilirubinemia can affect coagulation newborn, the clinical diagnosis and treatment of newborns should efficacy exclude bleeding disorders affect hyperbilirubinemia.